News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
Clovis Oncology (CLVS) (Once Again) Becomes a Takeover Topic, But Some Wonder Whether It's All Hype 9/23/2016
H. Lundbeck A/S (LUN.CO)'s Phase III Data Crushes Hope for Alzheimer’s Once Again 9/23/2016
Ireland Makes Its Case to Be New Home for the EMA Following Brexit 9/23/2016
35 U.S. States Sue British Drugmaker Indivior Over Marketing of Opioid 9/23/2016
Valeant (VRX) Slaps 'For Sale' Sign on iNova Pharma, Deal Could Bring in $1 Billion+ 9/23/2016
Gilead (GILD) Terminates Phase II/III Study of Ulcerative Colitis Drug 9/22/2016
What's Going On With The Biotech Job Market? 9/22/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic 9/22/2016
Pharma Bro Warned You: Mast Therapeutics (MSTX) Craters After Drug Flunks Phase III Test, Job Cuts Expected 9/22/2016
Calico Responds to Job Cut Rumors 9/22/2016
Drumroll, Please...GlaxoSmithKline (GSK) Just Named This Woman Its New CEO 9/22/2016
Avadim Tech to Create 551 Jobs at New N.C. HQ 9/22/2016
Allergan (AGN)'s NASH Spree Continues With $50 Million+ Buyout of San Diego's Akarna Therapeutics 9/21/2016
Struggling Eleven Bio (EBIO) Scoops Up Canadian Biotech, CEO Steps Down 9/21/2016
Vertex (VRTX) TV Show Seeks Help From Boston Heavyweights Like Matt Damon or Mark Wahlberg 9/21/2016
Bay Area-based Bulletproof Documentation Looks to Make a Name in the Life Science Technical Writing Market 9/21/2016
Pfizer (PFE) to Shut Down New York Plant, 120 Staffers Affected 9/21/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab 9/20/2016
Another Good Day for Amgen (AMGN) as Repatha Phase III GLAGOV Trial Met Primary, Secondary Endpoints 9/20/2016
Bayer (BAY) Considers Dropping Monsanto (MON) Name to Avoid 'Sullying Its Reputation' 9/20/2016
Why Rigel (RIGL)'s Layoffs May Not be a Bad Thing 9/19/2016
Amgen (AMGN), UCB Group (UCBJF.PK)'s Romosozumab Showed Significant Results in Phase III Study 9/19/2016
Spectrum Pharma (SPPI) Allegedly Hid a Key Detail From a Meeting With the FDA 9/19/2016
Bayer (BAY), Monsanto (MON)'s $66 Billion Marriage Could Cost 6,666 U.S. Jobs 9/19/2016
Novavax (NVAX) Stayin' Alive After Shares Crater on Flunked Phase III 9/19/2016
Could Biotech's Bestie Celgene (CELG) Be Getting Ready to Unveil Another Deal? 9/19/2016
Boston 'Unicorn' Intarcia Banks a Whopping $215 Million to Support Diabetes Drug Pump 9/19/2016
Flooding Halts Work at GlaxoSmithKline (GSK) Plant 9/16/2016
Hungry Like a Wolf, Takeda (TKPYY) Sets Aside $15 Billion Cash for U.S. Acquisitions 9/16/2016
Could There be a Marriage Between Valeant (VRX) and Allergan (AGN)? 9/15/2016
Boston's Ginkgo BioWorks Brews Up Jobs and Beer 9/15/2016
The Lone Star State's Peloton Therapeutics Rakes in $52.4 Million 9/15/2016
Bayer (BAY), Monsanto (MON) Give No Clues on How the $66 Billion Merge Will Impact RTP Jobs 9/15/2016
Spending Spree Continues as Allergan (AGN) Pays $639 Million for Vitae Pharma (VTAE) 9/15/2016
People of Indiana Disappointed as World's Richest Doctor's NantWorks Will Not Expand at Old Pfizer (PFE) Property 9/14/2016
How Sweet It is as Bayer (BAY) Finally Clinches Monsanto (MON) With $66 Billion Deal 9/14/2016
Good or Bad? Pharma Bro Thinks Jazz Pharma (JAZZ) Could be Worth $20 Billion, Calls Mast Therapeutics (MSTX) 'Worthless' 9/14/2016
How Arizona Republicans Also Fell Head-Over-Heels for Theranos's Elizabeth Holmes 9/14/2016
2 Bargain Pharma Stocks to Snag No Matter Who is Elected 9/14/2016
Another One Bites the Dust... Horizon Pharma (HZNP) Takes Out Bay Area's Raptor (RPTP) in $800 Million Deal 9/14/2016
BOO! Big Pharmas Like GlaxoSmithKline (GSK), Pfizer (PFE) and Mylan (MYL) Use Scare Tactics to Drum Up Sales 9/13/2016
Struggling AVEO Oncology (AVEO) Quietly Discontinues Phase II Ficlatuzumab Study 9/13/2016
Pharma Bro Martin Shkreli Heckles Hillary Clinton: 'Are You Alive?' 9/12/2016
Let's Not Stay Together...Takeda (TKPYY) and MacroGenics (MGNX) Nix Agreement 9/12/2016
Lexicon Pharma (LXRX) Rockets on Late-Stage Diabetes Drug Data 9/12/2016
Clovis Oncology (CLVS) Stock Jumps as FDA Skips Review Panel for New Cancer Drug 9/12/2016
New Details of Theranos Implosion Makes Great Fodder for Jennifer Lawrence Movie 9/9/2016
5 Myths About Mylan (MYL)'s EpiPen Scandal 9/9/2016
Juno (JUNO) Surges as Small Cancer Study is Hailed a Success, Shows Promise for Other Drugs 9/9/2016
Advice for Biogen (BIIB): Take a Page Out of Biotech's Best Friend Celgene (CELG)'s Playbook 9/9/2016
Deflated Tokai Pharma (TKAI) to Review Strategic Alternatives, Including Possible Sale 9/8/2016
San Diego's Fate Therapeutics (FATE) Lands a Deal With Star Scientist to Work on Off-the-Shelf T-Cell Immunotherapies 9/8/2016
5 Biotechs Under $10 With Massive Potential 9/8/2016
Juno (JUNO), Kite Pharma (KITE) Fall After Novartis AG (NVS) Dissolves CAR-T Unit 9/6/2016
Danaher (DHR) Coughs Up About $4 Billion for Diagnostics Maker Cepheid (CPHD) 9/6/2016
Novartis AG (NVS) Purges Senior Execs as It Carts Itself Off 9/6/2016
Mylan (MYL) Rebuffs Rumors CEO Will Step Down 9/6/2016
Roche (RHHBY) to Streamline Operations in Switzerland, 190 Workers Affected 9/2/2016
PAREXEL (PRXL) Loses $160 Million in Value in One Day After Disclosing Possible 'Misappropriation of Corporate Funds' 9/2/2016
GlaxoSmithKline (GSK) Opens Up 'Smart Space' to Test New Technology 9/2/2016
Cidara (CDTX) CMO Jumps Ship to Helm Unnamed Bay Area Biotech 9/2/2016
Novartis AG (NVS) to Dissolve Cell and Gene Therapy Unit, Move Affects 400 Staffers 9/2/2016
Massachusetts' Sunovion Swallows Up Cynapsus (CYNA) in $624 Million Deal, Gains Experimental Parkinson's Drug 9/1/2016
More Trouble for Theranos as FDA Discovers Company Cut Corners With Zika Test 9/1/2016
GenVec (GNVC) Will Not be Affected by Novartis AG (NVS)' Dissolution of CAR-T Unit 9/1/2016
Onconova (ONTX) Quietly Terminates Another 21% of Its Workforce 8/31/2016
Crown Bioscience Names a New CEO and CFO 8/31/2016
Bay Area Startup Arcus Biosciences Emerges With $120 Million 8/30/2016
2 Biotech Stocks Billionaire Investor George Soros Dumped. Should You? 8/30/2016
Mylan (MYL) CEO in 2006 Slammed Practice It’s Now Using on EpiPen 8/30/2016
With 11 Drugs in the Pipeline Already, Cash-Rich Moderna Eyes Another $600 Million 8/30/2016
Atlanta's Immucor to Expand in Milwaukee, Will Hire 64 New Employees 8/30/2016
AbSci Inks Lease for New HQ in Washington, Plans to Hire 8/30/2016
23andMe Ancestry Tests Allegedly Have Issues With People of Color 8/30/2016
Massachusetts Cancer Diagnostics Company Mitra Biotech Scores $27.4 Million 8/29/2016
Facing Public Backlash and Pressure from Clinton, Mylan (MYL) Caves and Lowers Price of EpiPen 8/26/2016
Job Cuts Loom as Takeda (TKPYY) to Shutter Cambridge Office and Quits the UK 8/26/2016
Embattled Theranos Plans to Appeal to Re-Open Its Lab in Newark, California 8/26/2016
Best Places to Work in Life Sciences for LGBT Equality 8/25/2016
Teva (TEVA) Stock Plummets After Two Patents are Invalidated by Mylan (MYL) 8/25/2016
Mylan (MYL) CEO Gets a 600% Pay Raise During Epipen's 400% Price Hike, Is She the Next Martin Shkreli? 8/25/2016
McKesson (MCK) Slaps 'For Sale' Sign on San Francisco HQ With Plans to Lease Back a Portion of Building 8/25/2016
Months After Infamous 'Sexist' Biotech Party, 20 Women Join New Exec Training 8/25/2016
Turing CCO Claims Execs Retaliated After Shkreli’s Friend and Co-Founder Resigned Due to Sexual Assault Allegations 8/25/2016
MIT Scientist Leonard Guarente Claims That This Pill Is the Fountain of Youth 8/25/2016
Valeant (VRX) Offers Details on Incoming CFO's Compensation; Will Get $10 Million in 'Make-Up Cash' 8/24/2016
Outrage Ensues After Mylan (MYL) Raises EpiPen Price by 400% 8/24/2016
Pfizer (PFE) to Shut Down Four Hospira Distribution Centers 8/24/2016
Merrion Pharma Looks to Wind Up Operations, Announces Liquidation Plans 8/23/2016
Advaxis (ADXS)' Resurrection and the Man Behind It All 8/23/2016
Google (GOOG)'s Verily HQ in the Peninsula Needs More Time, Company Seeks Timeline Extension 8/23/2016
Rumors Again Swirl Over BioMarin (BMRN) Being a Possible Plan B for Sanofi (SNY) 8/23/2016
DS Biopharma Spins Out New Company Focused on Fibrotic Conditions and Pulmonary Disorders 8/22/2016
Booming Arbutus Biopharma (ABUS) Relocating HQ to Warminster for More Space 8/22/2016
Nephron Pharma Chops Another 60 Jobs as it Transitions Out of Florida and Into New South Carolina HQ 8/22/2016
Korean Firms Acquire Novo Nordisk A/S (NVO)’s U.S. HQ for $305 Million 8/19/2016
2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now 8/19/2016
Trial Failure Prompts Cerulean (CERU) to Pink Slip 48% of Workforce 8/19/2016
Mallinckrodt (MNK) to Build New $80 Million+ Campus in New Jersey With Space for 400 Employees 8/19/2016
Juno (JUNO) Facing Class Action Lawsuit Following Patient Deaths 8/19/2016
19 Deaths Force Medtronic (MDT) to Warn Doctors on Heart Valve Delivery System 8/18/2016
Martin Shkreli's Former Firm Retrophin (RTRX) Considering Acquisition of Bay Area's Raptor (RPTP), Deal Could be Worth $589 Million+ 8/18/2016
Merck & Co. (MRK) Slashes 148 Jobs, Shuts Down Screening Plant in Montgomery County, Pennsylvania 8/18/2016
Life Sciences Symposium Lands Pharma Bro Martin Shkreli for Program Lineup 8/17/2016
GlaxoSmithKline (GSK) Best-Selling Weight Loss Pill Cramped By Problematic Studies That Understated Its Harms 8/17/2016
SEC Filing Reveals NW Bio (NWBO) May No Longer be Capable of Paying Its Operating Expenses 8/17/2016
Recordati CEO Dies; Drug Giant Urgently Names New CEO 8/17/2016
Roche (RHHBY), Eleven Bio (EBIO) Ink $270 Million Exclusive Licensing Deal 8/17/2016
Vertex (VRTX) Dumps Phase III Cystic Fibrosis Study 8/17/2016
Chiasma Enforces Job-Cutting Scheme, Axing a Further 44% of Workforce 8/16/2016
Bristol-Myers Squibb (BMY) Investors: Wait on Opdivo Data to See Potential in Lung Cancer 8/15/2016
Bayer HealthCare (BAY) to Lay Off Researchers in San Francisco's Mission Bay 8/15/2016
Amid Multi-Million Financing and Expanding Exec Management, SoCal's NovaRx Changes Company Name 8/15/2016
ProNAi Therapeutics Shuts Down Research Site for Failed Cancer Candidate PNT2258 8/15/2016
Struggling Eleven Bio (EBIO) Explores Sale of the Company 8/12/2016
Six Former and Current Novartis AG (NVS) Execs Charged With Bribing Doctors in Korea 8/12/2016
Investment Consultant and Lawyer Accused of Insider Trading Ahead of Pfizer (PFE)'s 2010 Acquisition of King Pharma 8/12/2016
Genome Revolution Drives Bay Area Teknova to Grow by 40 Percent; Company Wants to Expand and Double Workforce 8/12/2016
Novartis AG (NVS) Faces Potential Sales Ban in South Korea Amid Corruption Allegations 8/12/2016
Abbott (ABT) Managers in India Allegedly Instructed Employees to Pursue Sales at Any Cost 8/11/2016
Ranbaxy Laboratories (RANBAXY.BO) Owners ‘Deliberately Buried’ Information From Daiichi Sankyo: Singapore Tribunal Order 8/11/2016
Full Spectrum Analytics Provides the Total Fix for the Customer 8/11/2016
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial 8/10/2016
Agilent (A) Snaps Up 20 Acres in Colorado to Build Facility, Will Create Up to 200 New Jobs 8/10/2016
Biogen (BIIB) Unveils Name for New Standalone Hemophilia-Focused Company: Bioverativ 8/10/2016
AstraZeneca PLC (AZN)'s Lung Cancer Drug Flunks Late-Stage Test 8/10/2016
Baxter International (BAX), Torrent Pharma and Others Reportedly in Talks to Acquire CLARIS U.S. Injectables Unit 8/10/2016
Embattled Valeant (VRX) to Finally Reorganize, CEO Urges Patience 8/9/2016
Bristol-Myers Squibb (BMY)'s $4 Billion Disaster Sends Partner Ono Pharma (OPHLY)'s Stock Plunging 8/9/2016
WuXi AppTec's Subsidiary to Open Up Shop in San Diego 8/9/2016
Cytel President Explains Benefits of Adaptive Trial Design 8/9/2016
Bay Area's Cleave Biosciences Rakes in $37 Million With Help From New Investor Celgene (CELG) 8/8/2016
Doctor Charged With Insider Trading While Heading a Clinical Trial for Regado Biosciences (RGDO) 8/8/2016
Some AACC Scientists Quit the Organization Over Theranos CEO’s High-Profile Speaking Slot 8/8/2016
Vaxart Challenges Takeda (TKPYY) with Oral Norovirus Vaccine 8/8/2016
Ionis Pharma (IONS) Investors Still Nervous Despite Upbeat Trial Data Presented Earlier This Week 8/5/2016
AstraZeneca PLC (AZN) Firing and Hiring at Its Mt. Vernon Facility 8/5/2016
FDA Warns Chinese Drugmaker Xiamen Origin Biotech Over Making False Statements to Regulators 8/5/2016
Year-Old Startup Decibel Therapeutics Inks Lease for Huge New HQ in Boston 8/5/2016
McKesson (MCK) to Increase Headcount at Iowa Facility 8/5/2016
Bristol-Myers Squibb (BMY)'s Failed Lung Cancer Data Sends Stock Plunging 8/5/2016
Amgen (AMGN) Forges Pre-clinical R&D Pact Worth $540 Million With Advaxis (ADXS) 8/4/2016
Chemours HQ to Stay Put, Keeping 1,000 Jobs in Delaware 8/4/2016
Chemours to Begin First Wave of Niagara Falls Layoffs on Halloween, Second Wave on Dec. 31 8/4/2016
Theranos CEO Quietly Steps Down as Obama's Presidential Ambassador for Entrepreneurship 8/4/2016
Mayne Pharma Commits $80 Million to North Carolina Expansion After Acquiring 42 Products from Allergan (AGN), Teva (TEVA) 8/4/2016
7 Biotech Stocks Investors Should Keep Their Eye On in 2017 8/3/2016
Another Round of Layoffs for Pfizer (PFE) in New York 8/3/2016
GlaxoSmithKline (GSK), Google (GOOG)'s Verily Create $715 Million Bioelectronic Medicines Firm 8/3/2016
India's Aurobindo Pharma (AUROBINDOP.BO) Breaks Ground on U.S. HQ, Will Create Up to 400 Jobs 8/3/2016
Celgene (CELG) Accused of Donating Millions to Charities as Part of a Business 'Scheme to Gain Billions’ 8/3/2016
Struggling Telesta (TSX:TST) Cuts Another 30% of Workforce, Will Shutter Montreal Facility 8/2/2016
Embattled Theranos and Elizabeth Holmes' Next Bet: Project Edison 8/2/2016
Tokai Pharma (TKAI) Axes 60% of Workforce After Phase III Prostate Cancer Trial Failure 8/1/2016
Once-Booming NewLink Genetics (NLNK) to Eliminate 100 Jobs in Reorg 8/1/2016
In Revamp, Takeda (TKPYY) to Now Focus on Three Therapeutic Areas and Concentrate R&D Activities in Japan and the U.S. 8/1/2016
Theranos Will Finally Step Up to the Scientific Spotlight Next Week But Doubts Abound 7/29/2016
Seres Therapeutics (MCRB) Craters in Phase II ECOSPOR Study; CEO and Execs Profit on Insider Sales 7/29/2016
Amgen (AMGN) Restructuring Plan That Laid Off Hundreds Is Paying Off, CEO Says 7/29/2016
Pfizer (PFE) Plans $146 Million Expansion in Michigan 7/29/2016
Unilife  (UNIS) Axes 40% of Workforce, Names New CEO 7/28/2016
Eli Lilly (LLY)'s Longtime CEO to Retire, Successor Named 7/28/2016
Future Eli Lilly (LLY) CEO Says Dealmaking Will Be a Focus 7/28/2016
Why Gilead (GILD) Should Take a Page Out of Celgene (CELG)'s Playbook, But Will Have Trouble Doing So 7/28/2016
Miniature Microscopy Company Mauna Kea Technologies Takes New Approach to Commercial Strategy 7/28/2016
With Hopes of Bolstering Sanofi (SNY)’s Sagging Diabetes Sector, Announces FDA Approval of Adlyxin in U.S. 7/28/2016
Boehringer Ingelheim Halts Two Phase III Trials for Lung Cancer Drug Gilotrif 7/27/2016
Abbott (ABT) Sales Rep in India Blames Company in Suicide Note 7/27/2016
400+ Women are Suing Drug Giant Merck & Co. (MRK) Over Unequal Pay 7/27/2016
Clinton Running Mate Tim Kaine Scrutinized for Private Plane Ride Provided by Teva (TEVA) Subsidiary 7/26/2016
French-Based Firm Advanced Accelerator Applications Opens Up Shop in New Jersey, Plans to Hire 7/26/2016
Following Revelations of ‘Flawed Studies’ in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG (NVS) and Teva (TEVA) 7/26/2016
Takeda (TKPYY) May Sell Some Non-Core Assets to Raise Cash 7/26/2016
Tobira (TBRA) Stock Loses More Than Half Its Value After Phase IIb Trial Miss 7/25/2016
Galenica (GALN.SW) to Acquire Bay Area's Relypsa (RLYP) for $1.53 Billion 7/22/2016
3 Biotech Stocks That Could Explode in the Next 12 Months 7/22/2016
FDA Rejects Valeant (VRX) Glaucoma Drug, Raises Concerns Over Manufacturing Issues 7/22/2016
Fresenius SE Bid for Pfizer (PFE)'s Pump Biz Stalled, Pfizer Seeking Other Attractive Offers 7/22/2016
In Effort to Reform, Struggling Theranos Hires New Chiefs to Help Pull It Out of Its Ditch 7/22/2016
Drug Giant Merck & Co. (MRK) to Set Up Shop in South San Francisco 7/21/2016
Struggling Aegerion (AEGR) Axes 13% of Workforce, Withdraws Cholesterol Drug from the EU 7/21/2016
Celgene (CELG) Exec Takes Leave to Work on Trump Campaign 7/21/2016
GHO Capital Announces Acquisition Of Caprion (CAPR) 7/20/2016
Startup Bioz Launches With First Search Engine Built for Life Science Research 7/20/2016
Amgen (AMGN) and Merck KGaA (MKGAF.PK) Invest in Boston's Akili, Increasing Funding Round to $42.4 Million 7/20/2016
Merck KGaA (MKGAF.PK) Starts Construction on $115 Million Life Sci Hub in Massachusetts 7/19/2016
SoCal's Ionis Pharma (IONS) Cuts GI Deal Worth $810 Million With Janssen Biotech (JNJ) 7/19/2016
Former Epizyme (EPZM) CEO Helms Fulcrum Therapeutics; New Startup Banks $55 Million Series A 7/19/2016
Genentech (RHHBY) Receives a Blow After Lymphoma Drug Flunks Phase III Test 7/19/2016
Why Drugmakers like Merck & Co. (MRK), Shire (SHPG) and AstraZeneca PLC (AZN) Leave Philadelphia for Boston 7/19/2016
R&D Logic Provides Fourth Dimension Solution to Life Science Finance Software Platform 7/19/2016
FDA Panel Divided on Valeant (VRX)'s Psoriasis Drug Suicide Risk 7/18/2016
3 Big Pharmas That Have Plenty of Cash to Pay Out Investors 7/18/2016
Employee Taken to Hospital After Genentech (RHHBY) Hazmat Spill in South San Francisco 7/18/2016
Pharma Bro Martin Shkreli Gets Trial Date, Couldn’t Wait to Play Pokémon Go After Hearing 7/18/2016
European Regulator Calls XBiotech (XBIT)'s Phase III Cancer Data Unreliable 7/15/2016
Merck & Co. (MRK) Plans to Open Microbiome R&D Site in Former Idenix (IDIX) Facility in Cambridge 7/15/2016
NanoString (NSTG) Expands; New Biotech Silverback Therapeutics Sets Up Shop 7/14/2016
Germany's Vetter Plans to Hire 300 to Staff New Facility in Illinois 7/14/2016
Gilead (GILD) Used Legal Loopholes to Avoid Paying $10 Billion in Taxes Last Year 7/14/2016



//-->